(Q44098055)

29 November 2017

title

The reversal of extrapyramidal side effects with SCH 39166, a dopamine D1 receptor antagonist (English)

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90268-U

29 October 2022

main subject

extrapyramidal symptoms

1 reference

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90268-U

29 October 2022

author name string

McHugh D

1

1 reference

29 November 2017

D. McHugh

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1686252

29 October 2022

V. Coffin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1686252

29 October 2022

language of work or name

English

0 references

publication date

1 September 1991

1 reference

29 November 2017

4 September 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1686252

full work available at URL

29 October 2022

https://api.elsevier.com/content/article/PII:001429999190268U?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90268-U

https://api.elsevier.com/content/article/PII:001429999190268U?httpAccept=text/plain

29 October 2022

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90268-U

European Journal of Pharmacology

29 October 2022

published in

1 reference

29 November 2017

volume

202

1 reference

29 November 2017

issue

1

1 reference

29 November 2017

page(s)

133-134

1 reference

SCH 39166, a potential antipsychotic drug, does not evoke movement disorders in cebus monkeys

29 November 2017

cites work

3

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90268-U

29 October 2022

Identifiers

1 reference

29 November 2017

1 reference